“…Başsorgun et al in their study of 28 patients from Turkey in 2015 evaluated the epidermal and dermal changes that would predict the histopathological diagnosis of cutaneous leishmaniasis and found that epidermal thinning/thickening, and orthokeratosis were early stage indicators, while exocytosis, hyperparakeratosis, and epidermal thinning were indicative of late stage disease [18]. Highly unlikely forms of presentation usually show a marked acanthosis or even wide areas of necrosis that can mimic other conditions such as squamous cell carcinoma, deep fungal infection or secondary syphilis, granulomatous lesions (sarcoidal and elastolytic) and simulating lupoid rosacea or granuloma annulare [19,20]. Non specific pathologies which can coexist with cutaneous leishmaniasis include inflammatory diseases (panniculitis, subacute spongiotic dermatitis, lichen planus) or infectious/granulomatous conditions (tuberculosis-like lesions, sarcoidosis, pityriasis lichenoides, indeterminate leprosy), and neoplastic lesions (mycosis, anaplastic T-cell lymphoma).…”